Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.
Press releases published on May 15, 2025
Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts
GlobeNewswire
·
May 15, 2025
– Two subtype specific cohorts with ~15 patients each added to the ongoing RESET-Myositis™ trial – – RMAT designation granted for rese-cel in myositis, which is a disabling, multi-system autoimmune disease affecting approximately 80,000 U.S. …
Aya Gold & Silver Publishes 2024 Sustainability Report
GlobeNewswire
·
May 15, 2025
MONTREAL, May 15, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce that is has published its 2024 Sustainability Report for the year ended December 31, 2024 (the “Report”). The …
L’usine pilote du Réacteur de Silice Pyrogénée de HPQ franchit un jalon important en produisant un volume significatif de matériaux
GlobeNewswire
·
May 15, 2025
MONTRÉAL, 15 mai 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans le développement de nouveaux procédés industriels souhaite informer ses actionnaires …
HPQ Fumed Silica Pilot Produces Significant Material Volumes in Key Milestone
GlobeNewswire
·
May 15, 2025
MONTREAL, May 15, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company developing next-generation processes for advanced material manufacturing, would like to inform shareholders that …
Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 15, 2025
- Announced robust preclinical data supporting the unique three-pronged mechanism of action of micvotabart pelidotin (MICVO, formerly PYX-201), driving anti-tumor activity via direct tumor killing, bystander effect and immunogenic cell death - On track to …
Oroco Announces Major Initiatives
GlobeNewswire
·
May 15, 2025
VANCOUVER, Canada, May 15, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO; OTC: ORRCF) (“Oroco” or the “Company”) is pleased to announce three pivotal developments that mark significant steps forward for the Company and its flagship Santo Tomás …
Parexel Unveils New Industry Report: Global Survey of More Than 500 Pharmaceutical, Biotech and CRO Leaders & Frontline Workers Highlights Key Workforce Trends & Opportunities
GlobeNewswire
·
May 15, 2025
Artificial Intelligence (AI) Identified as a Key Area for Continued Workforce Training …
Bon Natural Life Limited Announces Effectiveness of Reverse Stock Split
GlobeNewswire
·
May 15, 2025
XI’AN, China, May 15, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that it will effect a …
AMERICAN SALARS ADDS LITHIUM BRINE EXPERT DR. MARK KING AS A TECHNCIAL ADVISOR AND QUALIFIED PERSON
GlobeNewswire
·
May 15, 2025
VANCOUVER, BC, May 15, 2025 (GLOBE NEWSWIRE) -- AMERICAN SALARS LITHIUM INC. ("AMERICAN SALARS" OR THE "COMPANY") (CSE: USLI, OTC: ASALF, FWB: Z3P, WKN: A3E2NY) announces the addition of Dr. Mark King PhD, PGeo, FGC, a world-renowned lithium brine expert, …
CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
GlobeNewswire
·
May 15, 2025
KUALA LUMPUR, MALAYSIA, May 15, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines, today announced its first quarter financial …
FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil®
GlobeNewswire
·
May 15, 2025
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received seven years of orphan-drug exclusive approval from U.S. Food and …